The board of directors of CSPC Pharmaceutical Group Limited hereby announced that with effect from 25 May 2018, Mr. PAN Weidong (Mr. PAN), an executive director of the company, ceased as rotating chief executive officer of the company and remains as executive director and vice-chairman of the company; and Mr. WANG Zhenguo (Mr. WANG), an executive director of the company, has been appointed as the vice-chairman and rotating chief executive officer of the company. Mr. WANG was appointed as an executive director of the company in 2012. Mr. Wang is also a director of certain subsidiaries of the group.